180 related articles for article (PubMed ID: 25798997)
21. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
Sen L; Cui G; Sakaguchi Y; Singh BN
J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
[TBL] [Abstract][Full Text] [Related]
23. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
[TBL] [Abstract][Full Text] [Related]
24. Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.
Boriani G; Biffi M; De Simone N; Bacchi L; Martignani C; Bitonti F; Zannoli R; Butrous G; Branzi A
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1935-8. PubMed ID: 11139961
[TBL] [Abstract][Full Text] [Related]
25. Reproducibility of QTc interval changes after meal intake.
Hnatkova K; Kowalski D; Keirns JJ; van Gelderen EM; Malik M
J Electrocardiol; 2015; 48(2):194-202. PubMed ID: 25601409
[TBL] [Abstract][Full Text] [Related]
26. Effects of Sotalol on the Circadian Rhythmicity of Heart Rate and QT Intervals With a Noninvasive Index of Reverse-Use Dependency.
Sharma PP; Sarma JS; Singh BN
J Cardiovasc Pharmacol Ther; 1999 Jan; 4(1):15-21. PubMed ID: 10684520
[TBL] [Abstract][Full Text] [Related]
27. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
28. The time course of new T-wave ECG descriptors following single- and double-dose administration of sotalol in healthy subjects.
Extramiana F; Dubois R; Vaglio M; Roussel P; Dreyfus G; Badilini F; Leenhardt A; Maison-Blanche P
Ann Noninvasive Electrocardiol; 2010 Jan; 15(1):26-35. PubMed ID: 20146779
[TBL] [Abstract][Full Text] [Related]
29. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.
Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA
J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348
[TBL] [Abstract][Full Text] [Related]
30. Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.
Extramiana F; Badilini F; Sarapa N; Leenhardt A; Maison-Blanche P
J Clin Pharmacol; 2007 Sep; 47(9):1129-37. PubMed ID: 17656619
[TBL] [Abstract][Full Text] [Related]
31. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.
Molnar J; Zhang F; Weiss J; Ehlert FA; Rosenthal JE
J Am Coll Cardiol; 1996 Jan; 27(1):76-83. PubMed ID: 8522713
[TBL] [Abstract][Full Text] [Related]
32. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
Chaikin P; Gillen MS; Malik M; Pentikis H; Rhodes GR; Roberts DJ
Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
[TBL] [Abstract][Full Text] [Related]
33. Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol.
Stark G; Schwarzl I; Heiden U; Stark U; Tritthart HA
Cardiovasc Res; 1997 Jul; 35(1):43-51. PubMed ID: 9302346
[TBL] [Abstract][Full Text] [Related]
34. Statistical characteristics of moxifloxacin-induced QTc effect.
Yan LK; Zhang J; Ng MJ; Dang Q
J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.
Barbey JT; Sale ME; Woosley RL; Shi J; Melikian AP; Hinderling PH
Clin Pharmacol Ther; 1999 Jul; 66(1):91-9. PubMed ID: 10430114
[TBL] [Abstract][Full Text] [Related]
36. The effects of moxifloxacin on QTc interval in healthy Korean male subjects.
Moon SJ; Lee J; An H; Yim DS; Chung JY; Yu KS; Cho JY; Lim KS
Drugs R D; 2014 Jun; 14(2):63-71. PubMed ID: 24691742
[TBL] [Abstract][Full Text] [Related]
37. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A
Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329
[TBL] [Abstract][Full Text] [Related]
38. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
[TBL] [Abstract][Full Text] [Related]
39. Man versus Machine: Comparison of Automated and Manual Methodologies for Measuring the QTc Interval: A Prospective Study.
Barbey JT; Connolly M; Beaty B; Krantz MJ
Ann Noninvasive Electrocardiol; 2016 Jan; 21(1):82-90. PubMed ID: 25944685
[TBL] [Abstract][Full Text] [Related]
40. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
